Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Клинико-ультрасонографическая оценка эффективности левоцетиризина (Гленцета) у больных экземой
Клинико-ультрасонографическая оценка эффективности левоцетиризина (Гленцета) у больных экземой
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Полный текст
Список литературы
1. Rathod RT, Misra D. FDC of montelukast with levocetirizine: focus on bilayer technology. J Indian Med Assoc 2009; 107 (8): 562–4.
2. Wu P, Mitchell S, Walsh GM. A new antihistamine levocetirizine inhibits eosinophil adhesion to vascular cell adhesion molecule-1 under flow conditions. Clin Exp Allergy 2005; 35 (8): 1073–9.
3. Hansen J, Klimek L, Hörmann K. Pharmacological management of allergic rhinitis in the elderly: safety issues with oral antihistamines. Drugs Aging 2005; 22 (4): 289–96.
4. Giustizieri ML, Albanesi C, Fluhr J et al. H1 histamine receptor mediates inflammatory responses in human keratinocytes. J Allergy Clin Immunol 2004; 114 (5): 1176–82.
5. Hasala H, Janka-Junttila M, Moilanen E et al. Levocetirizine and cytokine production and apoptosis of human eosinophils. Allergy Asthma Proc 2007; 28 (5): 582–91.
6. Singh-Franco D, Ghin HL, Robles GI et al. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children. Clin Ther 2009; 31 (8): 1664–87.
7. Walsh GM. A review of the role of levocetirizine as an effective therapy for allergic disease. Expert Opin Pharmacother 2008; 9 (5): 859–67.
8. Dubuske LM. Levocetirizine: The latest treatment option for allergic rhinitis and chronic idiopathic urticarial. Allergy Asthma Proc 2007; 28 (6): 724–34.
9. Simons FE. H1-antihistamine treatment in young atopic children: effect on urticaria. Early Prevention of Asthma in Atopic Children Study Group. Ann Allergy Asthma Immunol 2007; 99 (3): 261–6.
10. Dhanya NB, Rai R, Srinivas CR. Histamine 2 blocker potentiates the effects of histamine 1 blocker in suppressing histamine-induced wheal. Indian J Dermatol Venereol Leprol 2008; 74 (5): 475–7.
11. Hair PI, Scott LJ. Levocetirizine: a review of its use in the management of allergic rhinitis and skin allergies. Drugs 2006; 66 (7): 973–96.
12. Gillard M, Benedetti MS, Chatelain P et al. Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines. Inflamm Res 2005; 54 (9): 367–9.
13. Camelo-Nunes IC. New antihistamines: a critical view. J Pediatr (Rio J) 2006; 82 (Suppl. 5): S173–80.
14. Petecchia L, Serpero L. The histamine-induced enhanced expression of vascular cell adhesion molecule-1 by nasal polyp-derived fibroblasts is inhibited by levocetirizine. Am J Rhinol 2006; 20 (5): 445–9.
15. Walsh GM. Levocetirizine: an update. Curr Med Chem 2006; 13 (22): 2711–5.
2. Wu P, Mitchell S, Walsh GM. A new antihistamine levocetirizine inhibits eosinophil adhesion to vascular cell adhesion molecule-1 under flow conditions. Clin Exp Allergy 2005; 35 (8): 1073–9.
3. Hansen J, Klimek L, Hörmann K. Pharmacological management of allergic rhinitis in the elderly: safety issues with oral antihistamines. Drugs Aging 2005; 22 (4): 289–96.
4. Giustizieri ML, Albanesi C, Fluhr J et al. H1 histamine receptor mediates inflammatory responses in human keratinocytes. J Allergy Clin Immunol 2004; 114 (5): 1176–82.
5. Hasala H, Janka-Junttila M, Moilanen E et al. Levocetirizine and cytokine production and apoptosis of human eosinophils. Allergy Asthma Proc 2007; 28 (5): 582–91.
6. Singh-Franco D, Ghin HL, Robles GI et al. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children. Clin Ther 2009; 31 (8): 1664–87.
7. Walsh GM. A review of the role of levocetirizine as an effective therapy for allergic disease. Expert Opin Pharmacother 2008; 9 (5): 859–67.
8. Dubuske LM. Levocetirizine: The latest treatment option for allergic rhinitis and chronic idiopathic urticarial. Allergy Asthma Proc 2007; 28 (6): 724–34.
9. Simons FE. H1-antihistamine treatment in young atopic children: effect on urticaria. Early Prevention of Asthma in Atopic Children Study Group. Ann Allergy Asthma Immunol 2007; 99 (3): 261–6.
10. Dhanya NB, Rai R, Srinivas CR. Histamine 2 blocker potentiates the effects of histamine 1 blocker in suppressing histamine-induced wheal. Indian J Dermatol Venereol Leprol 2008; 74 (5): 475–7.
11. Hair PI, Scott LJ. Levocetirizine: a review of its use in the management of allergic rhinitis and skin allergies. Drugs 2006; 66 (7): 973–96.
12. Gillard M, Benedetti MS, Chatelain P et al. Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines. Inflamm Res 2005; 54 (9): 367–9.
13. Camelo-Nunes IC. New antihistamines: a critical view. J Pediatr (Rio J) 2006; 82 (Suppl. 5): S173–80.
14. Petecchia L, Serpero L. The histamine-induced enhanced expression of vascular cell adhesion molecule-1 by nasal polyp-derived fibroblasts is inhibited by levocetirizine. Am J Rhinol 2006; 20 (5): 445–9.
15. Walsh GM. Levocetirizine: an update. Curr Med Chem 2006; 13 (22): 2711–5.
Авторы
А.Л.Бакулев1, С.С.Кравченя1, Н.Н.Мурашкин2
1. ГОУ ВПО Саратовский ГМУ им. В.И.Разумовского Минздравсоцразвития РФ;
2. ГУЗ Краснодарский краевой клинический кожно-венерологический диспансер
1. ГОУ ВПО Саратовский ГМУ им. В.И.Разумовского Минздравсоцразвития РФ;
2. ГУЗ Краснодарский краевой клинический кожно-венерологический диспансер
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.